Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytoreductive Surgery
Cytoreductive surgery improves prognosis in ovarian metastasis
September 22nd, 2005
Cytoreductive surgery appears to improves prognosis in ovarian metastasis. Researchers in Turkey conducted a study "To investigate the role of cytoreductive surgery in patients with nongenital cancers metastatic to the ovaries. One hundred and fifty-four patients with nongenital cancers metastatic to the ovaries treated in Hacettepe University Hospital, Gynecologic Oncology Unit between 1982 and 2004 years were retrospectively evaluated. Data were obtained from patients' records and pathology reports." According to A. Ayhan and colleagues, "Demographic characteristics, prognostic factors, 5-year and median survivals were analyzed in all patients....
Source: Women's Health Weekly (2005-09-22)
|
